| Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. | |
| | |
MedLine Citation:
|
PMID: 10706897 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Approximately half of otherwise healthy adults with invasive pneumococcal disease are cigarette smokers. We conducted a population-based case-control study to assess the importance of cigarette smoking and other factors as risk factors for pneumococcal infections. METHODS: We identified immunocompetent patients who were 18 to 64 years old and who had invasive pneumococcal disease (as defined by the isolation of Streptococcus pneumoniae from a normally sterile site) by active surveillance of laboratories in metropolitan Atlanta, Baltimore, and Toronto. Telephone interviews were conducted with 228 patients and 301 control subjects who were reached by random-digit dialing. RESULTS: Fifty-eight percent of the patients and 24 percent of the control subjects were current smokers. Invasive pneumococcal disease was associated with cigarette smoking (odds ratio, 4.1; 95 percent confidence interval, 2.4 to 7.3) and with passive smoking among nonsmokers (odds ratio, 2.5; 95 percent confidence interval, 1.2 to 5.1) after adjustment by logistic-regression analysis for age, study site, and independent risk factors such as male sex, black race, chronic illness, low level of education, and living with young children who were in day care. There were dose-response relations for the current number of cigarettes smoked per day, pack-years of smoking, and time since quitting. The adjusted population attributable risk was 51 percent for cigarette smoking, 17 percent for passive smoking, and 14 percent for chronic illness. CONCLUSIONS: Cigarette smoking is the strongest independent risk factor for invasive pneumococcal disease among immunocompetent, nonelderly adults. Because of the high prevalence of smoking and the large population attributable risk, programs to reduce both smoking and exposure to environmental tobacco smoke have the potential to reduce the incidence of pneumococcal disease. |
| | |
Authors:
|
J P Nuorti; J C Butler; M M Farley; L H Harrison; A McGeer; M S Kolczak; R F Breiman |
Related Documents
:
|
1892287 - The influence of cigarette smoking on lung function in patients with idiopathic pulmona... 4068167 - Smoke exposure in pipe and cigar smokers. serum thiocyanate measures. 11906687 - Differential effects of cigarette price on youth smoking intensity. 21054617 - Does extinction of responses to cigarette cues occur during smoking cessation? 15710707 - Early and late mortality after myocardial infarction in men and women: prospective obse... 6580657 - Association of alcoholism and antisocial personality in a narcotic-dependent population... |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: The New England journal of medicine Volume: 342 ISSN: 0028-4793 ISO Abbreviation: N. Engl. J. Med. Publication Date: 2000 Mar |
Date Detail:
|
Created Date: 2000-03-09 Completed Date: 2000-03-09 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0255562 Medline TA: N Engl J Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 681-9 Citation Subset: AIM; IM |
Affiliation:
|
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult African Continental Ancestry Group Case-Control Studies Child Day Care Centers Chronic Disease Educational Status Female Humans Logistic Models Male Middle Aged Multivariate Analysis Pneumococcal Infections / epidemiology, etiology*, microbiology Risk Factors Sex Factors Smoking / adverse effects* Streptococcus pneumoniae / isolation & purification Tobacco Smoke Pollution / adverse effects* |
| Chemical | |
Reg. No./Substance:
|
0/Tobacco Smoke Pollution |
| Comments/Corrections | |
Comment In:
|
N Engl J Med. 2000 Mar 9;342(10):732-4
[PMID:
10706905
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.
Next Document: Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.